deltatrials
Completed OBSERVATIONAL NCT04005261

C-peptide Concentrations in Type 2 Diabetes Treated With Insulin; is it Time to Revise the Treatment of Type 2 Diabetes

Is it Time to Revise Type 2 Diabetes Treatment: C-peptide Concentrations in Type 2 Diabetes Treated With Insulin

Sponsor: Goztepe Training and Research Hospital

Conditions Type 2 Diabetes Treated With Insulin
Interventions C-peptide concentrations
Updated 5 times since 2019 Last updated: Jul 1, 2019 Started: Nov 1, 2018 Primary completion: Feb 1, 2019 Completion: Mar 1, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Type 2 Diabetes Treated With Insulin and is currently completed. Goztepe Training and Research Hospital leads this study, which shows 5 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Aug 2019 – ~Jan 2021 · 17 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

5 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed

  2. Sep 2024 — Sep 2025 [monthly]

    Completed

  3. Jul 2024 — Sep 2024 [monthly]

    Completed

  4. Jan 2021 — Jul 2024 [monthly]

    Completed

  5. Aug 2019 — Jan 2021 [monthly]

    Completed

    First recorded

Nov 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Goztepe Training and Research Hospital
Data source: Goztepe Training and Research Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations